Optimization of Treatment and Management of Schizophrenia in Europe (OPTIMISE): Substudy Site Copenhagen

NACompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

July 31, 2016

Study Completion Date

October 31, 2016

Conditions
SchizophreniaSchizophreniform DisorderSchizoaffective Disorder
Interventions
DRUG

Amisulpride

4-week open label amisulpride treatment

Trial Locations (1)

Unknown

Center for Neuropsychiatric Schizophrenia Research, University of Copenhagen, Psychiatric Center Glostrup Glostrup, Denmark, Glostrup Municipality

Sponsors
All Listed Sponsors
collaborator

Glostrup University Hospital, Copenhagen

OTHER

collaborator

Rigshospitalet, Denmark

OTHER

collaborator

Institute of Psychiatry, London

OTHER

collaborator

UMC Utrecht

OTHER

collaborator

Copenhagen Hospital Corporation

OTHER

lead

Birte Glenthoj

OTHER

NCT01555814 - Optimization of Treatment and Management of Schizophrenia in Europe (OPTIMISE): Substudy Site Copenhagen | Biotech Hunter | Biotech Hunter